A Phase I Study of GZR18 Injection in Obese/Overweight Subjects

Exclusion Criteria

• •Lactating women.
• •History of fainting with blood and needles.
• •Known or suspected allergy to study related products; or drug/food allergy history; or allergy-related diseases history.
• •Subjects who have participated in other clinical trials and given investigational drugs or medical device interventions within 90 days before screening.
• •History of drug abuse within 1 year before screening, or positive results in drug abuse screening (urine).
• •Smokers who smoke ≥ 5 cigarettes per day within the previous 3 months before screening or cannot refrain from smoking throughout the trial period.
• •Any vaccine has been used within 28 days before administration, as well as any vaccine that may be used throughout the trial period.
• •Other scenarios judged by the investigator to render the subjects unsuitable for participating in this study.